track injection sites semaglutide How to Inject Your Semaglutide/Tirzepatide (GLP-1 Analogs) Does it matter where you

Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: A prospective cohort study

Compound Receptors Peak trial weight loss Lean mass as share of loss Semaglutide (Ozempic/Wegovy) GLP-1 ~14.9% (STEP-1, 68 wk) ~39% Tirzepatide (Mounjaro/Zepbound) GLP-1 + GIP ~20.9% (SURMOUNT-1, 72 wk) ~25-40% Retatrutide GLP-1 + GIP + GCGR ~24.2% (Phase 2, 48 wk) Comparable class range Best for understanding the takeaway: the percentage of loss that is lean mass is roughly constant across the class

39(Suppl

This comprehensive review presents the state-of-the-art information on LCs dual role, emphasizing the balance between its therapeutic potential and the risks of prolonged supplementation